Twin Peaks Wealth Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-265
Closed -$4.45K 597
2026
Q1
$4.45K Buy
+265
New +$4.74K ﹤0.01% 1434

Other funds holding CLB

Twin Peaks Wealth Advisors's CLB Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 265 shares — an estimated $4.45K sold.

Twin Peaks Wealth Advisors first reported a position in CLB in Q1 2026 and held it in 1 quarter. The position peaked at $4.45K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 265 Core Laboratories shares in Q2 2026, an estimated $4.45K.
  • Twin Peaks Wealth Advisors first reported a position in Core Laboratories in Q1 2026 and held it in 1 quarter.
  • Twin Peaks Wealth Advisors's Core Laboratories position peaked at $4.45K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.